Toxicology Laboratory Industry Analysis in North America is Expected to Reach a Valuation of US$ 695.1 Million by 2034

The toxicology laboratory market in North America generated US$ 239.2 million in revenue in 2024. It is projected to grow at a CAGR of 11.3% over the forecast period, reaching a value of US$ 695.1 million by 2034.

This growth is primarily driven by increasing awareness of the importance of toxicological testing across various sectors. Stricter regulatory requirements, a growing demand for drug screening, and advancements in testing technologies are key factors propelling market expansion. Additionally, the rising emphasis on occupational health and environmental monitoring is further boosting the demand for toxicology laboratory services throughout the region.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9738

Which Economic Barriers Impede the Progress of Toxicology Laboratories in North America?

"Limited Funding and Regulatory Complexities Challenge Market Growth"

The progress of toxicology laboratories in North America is hindered by several economic and operational barriers. One of the primary challenges is fiscal restraint within research institutions and healthcare systems, which limits the availability of funding for toxicology services. This financial uncertainty reduces the pace of adoption and expansion across the region.

Additionally, laboratories face significant operational burdens due to stringent regulatory requirements and evolving compliance standards. Frequent updates to testing guidelines and the introduction of new regulations increase both the complexity and cost of operations. These factors collectively create a challenging environment for toxicology labs, slowing down market growth despite rising demand.

Country-wise Analysis

The rising demand for toxicology laboratory services in North America is primarily driven by the United States and Canada, the region's key contributors. Among them, the United States is projected to dominate the market with a substantial 72.8% share by 2034, solidifying its position as the leading country in the toxicology laboratory sector.

This strong growth highlights an increasing reliance on toxicology services to address critical public health and safety concerns. The expanding use of these laboratories underscores their importance in regulatory compliance, drug testing, and environmental monitoring, contributing to the sector's growing prominence across North America.

Category-wise Outlook

By drug class, the amphetamines segment is projected to capture a 27.1% share of the industry by 2034. The opiates/opioids segment is also expected to hold a significant portion, accounting for 21.0% of the market by the same year.

In terms of products, reagents and kits are forecasted to dominate the market with a 57.5% share by 2034. Instruments will continue to play an important role as well, representing 42.5% of the market.

Regarding sample types, urine testing is anticipated to lead with a 52.7% share by 2034, followed by oral fluids, which are expected to account for 24.3% of the market.

Competitive Analysis

Key players dominating the North American toxicology laboratory market include Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Alere, Inc., Bio-Rad Laboratories Inc., Neogen Corporation, Bruker, and Redwood Toxicology Laboratory. These leading companies are actively expanding their product portfolios to enhance core competencies, focusing on innovations that deliver optimal outcomes efficiently.

Manufacturers are also scaling up production capabilities and increasing their market share to meet the growing demand for toxicology testing services. To encourage adoption of new technologies, vendors emphasize unique selling points (USPs) through strategic innovations tailored to consumer needs.

Notable Breakthroughs and Innovations:

In June 2023, Lonza acquired Synaffix B.V., a company specializing in clinical-stage ADC (antibody-drug conjugate) technology. This acquisition strengthens Lonza's presence in North America, enhancing its manufacturing capabilities for pharmaceutical and biotech industries.
In May 2023, BML and Labcorp Drug Development announced plans to expand clinical laboratory testing capacities in Japan, reinforcing their product offerings and global footprint.
In December 2022, Merck KGaA and Mersana Therapeutics, Inc. entered a research collaboration and commercial license agreement aimed at discovering novel antibody-drug conjugates using Mersana's Immunosynthen STING-agonist ADC platform, targeting dual-action therapies.
Thermo Fisher Scientific Inc. expanded its laboratory operations in Highland Heights, Kentucky, in October 2022, enhancing services for biopharma clients and accelerating drug development. This move bolstered the company's clinical diagnostics capabilities and market share in North America.
PerkinElmer, Inc. introduced the GC 2400 Platform in June 2022, an advanced automated gas chromatography and mass spectrometry system designed to streamline lab workflows, improve accuracy, and offer greater monitoring flexibility.
These strategic developments highlight the sector's commitment to innovation and capacity expansion, positioning key players to better serve the evolving needs of the toxicology laboratory market in North America.

Browse Full Report: https://www.factmr.com/report/toxicology-laboratory-industry-analysis-in-north-america

Segmentation of Toxicology Laboratory Industry in North America

By Drug Class:
Alcohol
Amphetamines
Barbiturates
Benzodiazepines
Opiates/Opioids
Tricyclic Antidepressants
Z Drugs
By Product:
Instruments
Reagents and Kits
By Sample:
Urine
Blood
Hair
Oral Fluids
By End User:
Hospitals and Trauma Centers
Forensic Laboratories
Diagnostic Laboratories
Rehabilitation Centers
By Country:
United States
Canada

Check out More Related Studies Published by Fact.MR:

ATP Assay Market
https://www.factmr.com/report/atp-assay-market
Guidewires Market
https://www.factmr.com/report/4682/guidewires-market
PCR and Real-time PCR Molecular Diagnostics Market
https://www.factmr.com/report/5247/pcr-and-realtime-pcr-molecular-diagnostics-market
Nonmydriatic Handheld Fundus Cameras Market
https://www.factmr.com/report/nonmydriatic-handheld-fundus-cameras-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.